GB0525321D0 - Novel compositions - Google Patents

Novel compositions

Info

Publication number
GB0525321D0
GB0525321D0 GBGB0525321.6A GB0525321A GB0525321D0 GB 0525321 D0 GB0525321 D0 GB 0525321D0 GB 0525321 A GB0525321 A GB 0525321A GB 0525321 D0 GB0525321 D0 GB 0525321D0
Authority
GB
United Kingdom
Prior art keywords
novel compositions
compositions
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0525321.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GBGB0525321.6A priority Critical patent/GB0525321D0/en
Publication of GB0525321D0 publication Critical patent/GB0525321D0/en
Priority to TW095146300A priority patent/TWI457133B/en
Priority to ES11168827.1T priority patent/ES2436645T3/en
Priority to AT06831376T priority patent/ATE542543T1/en
Priority to KR1020087016980A priority patent/KR101363879B1/en
Priority to NZ596870A priority patent/NZ596870A/en
Priority to ES11168822.2T priority patent/ES2444623T3/en
Priority to EP11168820.6A priority patent/EP2364720B1/en
Priority to CN201410035418.6A priority patent/CN103861100A/en
Priority to BRPI0619795A priority patent/BRPI0619795B8/en
Priority to CN2013103564887A priority patent/CN103405764A/en
Priority to SG10201405533TA priority patent/SG10201405533TA/en
Priority to DK06831376.6T priority patent/DK1959992T3/en
Priority to CA2633008A priority patent/CA2633008C/en
Priority to AU2006325377A priority patent/AU2006325377B2/en
Priority to CNA2006800471395A priority patent/CN101330924A/en
Priority to ES11168820.6T priority patent/ES2479165T3/en
Priority to DK11168827.1T priority patent/DK2364724T3/en
Priority to PL06831376T priority patent/PL1959992T3/en
Priority to ES06831376T priority patent/ES2378471T3/en
Priority to EP11168821.4A priority patent/EP2364721B1/en
Priority to EP11168822.2A priority patent/EP2364722B1/en
Priority to PCT/GB2006/004634 priority patent/WO2007068907A2/en
Priority to UAA200807167A priority patent/UA98612C2/en
Priority to EP06831376A priority patent/EP1959992B1/en
Priority to MYPI20082050A priority patent/MY145943A/en
Priority to PL11168827T priority patent/PL2364724T3/en
Priority to NZ568825A priority patent/NZ568825A/en
Priority to ES11168821.4T priority patent/ES2445170T3/en
Priority to US12/096,838 priority patent/US20080279926A1/en
Priority to PL11168820T priority patent/PL2364720T3/en
Priority to SI200631300T priority patent/SI1959992T1/en
Priority to SG201101856-1A priority patent/SG170127A1/en
Priority to EP11168827.1A priority patent/EP2364724B1/en
Priority to DK11168820.6T priority patent/DK2364720T3/en
Priority to PT06831376T priority patent/PT1959992E/en
Priority to EA200801307A priority patent/EA014353B1/en
Priority to PT111688206T priority patent/PT2364720E/en
Priority to SI200631697T priority patent/SI2364724T1/en
Priority to PT111688271T priority patent/PT2364724E/en
Priority to CN2012101089032A priority patent/CN102631670A/en
Priority to EA201001189A priority patent/EA018860B1/en
Priority to EP11168826.3A priority patent/EP2364723B1/en
Priority to JP2008545078A priority patent/JP5461015B2/en
Priority to ES11168826.3T priority patent/ES2451573T3/en
Priority to SI200631793T priority patent/SI2364720T1/en
Priority to ARP060105496A priority patent/AR058543A1/en
Priority to PE2006001600A priority patent/PE20071098A1/en
Priority to IL191703A priority patent/IL191703A/en
Priority to NO20082472A priority patent/NO20082472L/en
Priority to MA30995A priority patent/MA30023B1/en
Priority to ZA200805025A priority patent/ZA200805025B/en
Priority to CR10101A priority patent/CR10101A/en
Priority to CR10118A priority patent/CR10118A/xx
Priority to HK11111652.3A priority patent/HK1157219A1/en
Priority to HK08110254.2A priority patent/HK1118477A1/en
Priority to US13/020,045 priority patent/US10039823B2/en
Priority to HR20120136T priority patent/HRP20120136T1/en
Priority to CY20121100324T priority patent/CY1112589T1/en
Priority to JP2012256348A priority patent/JP2013056927A/en
Priority to HRP20131057TT priority patent/HRP20131057T1/en
Priority to IL229521A priority patent/IL229521A0/en
Priority to CY20131101050T priority patent/CY1114864T1/en
Priority to HRP20140484TT priority patent/HRP20140484T1/en
Priority to CY20141100461T priority patent/CY1115308T1/en
Priority to US15/354,233 priority patent/US10143745B2/en
Priority to ARP170101607A priority patent/AR108718A2/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GBGB0525321.6A 2005-12-13 2005-12-13 Novel compositions Ceased GB0525321D0 (en)

Priority Applications (67)

Application Number Priority Date Filing Date Title
GBGB0525321.6A GB0525321D0 (en) 2005-12-13 2005-12-13 Novel compositions
TW095146300A TWI457133B (en) 2005-12-13 2006-12-11 Novel composition
ES11168827.1T ES2436645T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
AT06831376T ATE542543T1 (en) 2005-12-13 2006-12-12 IMMUNOGENIC COMPOSITION CONTAINING AN ADJUVANT
KR1020087016980A KR101363879B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
NZ596870A NZ596870A (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
ES11168822.2T ES2444623T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
EP11168820.6A EP2364720B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
CN201410035418.6A CN103861100A (en) 2005-12-13 2006-12-12 Vaccine compositions comprising saponin adjuvant
BRPI0619795A BRPI0619795B8 (en) 2005-12-13 2006-12-12 immunogenic composition, adjuvant composition, and, use of an immunogenic composition and an adjuvant
CN2013103564887A CN103405764A (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
SG10201405533TA SG10201405533TA (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
DK06831376.6T DK1959992T3 (en) 2005-12-13 2006-12-12 Immunogenic composition containing an adjuvant.
CA2633008A CA2633008C (en) 2005-12-13 2006-12-12 Novel composition
AU2006325377A AU2006325377B2 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
CNA2006800471395A CN101330924A (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
ES11168820.6T ES2479165T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
DK11168827.1T DK2364724T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
PL06831376T PL1959992T3 (en) 2005-12-13 2006-12-12 Immunogenic composition comprising an adjuvant
ES06831376T ES2378471T3 (en) 2005-12-13 2006-12-12 Immunogenic composition comprising an adjuvant
EP11168821.4A EP2364721B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
EP11168822.2A EP2364722B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
PCT/GB2006/004634 WO2007068907A2 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
UAA200807167A UA98612C2 (en) 2005-12-13 2006-12-12 Immunogenic composition useful for human individual comprising an antigen or antigenic preparation in combination with an adjuvant comprising qs21 in the form of a liposome and 3d-mpl
EP06831376A EP1959992B1 (en) 2005-12-13 2006-12-12 Immunogenic composition comprising an adjuvant
MYPI20082050A MY145943A (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
PL11168827T PL2364724T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
NZ568825A NZ568825A (en) 2005-12-13 2006-12-12 Vaccine adjuvant comprising saponin and lipopolysaccharide
ES11168821.4T ES2445170T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
US12/096,838 US20080279926A1 (en) 2005-12-13 2006-12-12 Vaccine Compositions Comprising a Saponin Adjuvant
PL11168820T PL2364720T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
SI200631300T SI1959992T1 (en) 2005-12-13 2006-12-12 Immunogenic composition comprising an adjuvant
SG201101856-1A SG170127A1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
EP11168827.1A EP2364724B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
DK11168820.6T DK2364720T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
PT06831376T PT1959992E (en) 2005-12-13 2006-12-12 Immunogenic composition comprising an adjuvant
EA200801307A EA014353B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
PT111688206T PT2364720E (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
SI200631697T SI2364724T1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
PT111688271T PT2364724E (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
CN2012101089032A CN102631670A (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
EA201001189A EA018860B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
EP11168826.3A EP2364723B1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
JP2008545078A JP5461015B2 (en) 2005-12-13 2006-12-12 Vaccine composition comprising saponin adjuvant
ES11168826.3T ES2451573T3 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
SI200631793T SI2364720T1 (en) 2005-12-13 2006-12-12 Vaccine compositions comprising a saponin adjuvant
ARP060105496A AR058543A1 (en) 2005-12-13 2006-12-13 NEW COMPOSITION OF VACCINE POTENTIATED WITH A LIPOSOMAL ASSISTANT
PE2006001600A PE20071098A1 (en) 2005-12-13 2006-12-13 IMMUGENIC COMPOSITION CONTAINING AS ADJUVANTS A SAPONIN AND A POLYSACCHARIDE
IL191703A IL191703A (en) 2005-12-13 2008-05-26 Immunogenic composition comprising an antigen, a saponin adjuvant and a lipopolysaccharide
NO20082472A NO20082472L (en) 2005-12-13 2008-05-29 Vaccine compositions comprising a saponin adjuvant
MA30995A MA30023B1 (en) 2005-12-13 2008-06-03 NEW COMPOSITION
ZA200805025A ZA200805025B (en) 2005-12-13 2008-06-09 Vaccine compositions comprising a saponin adjuvant
CR10101A CR10101A (en) 2005-12-13 2008-06-20 NEW COMPOSITION
CR10118A CR10118A (en) 2005-12-13 2008-06-26
HK11111652.3A HK1157219A1 (en) 2005-12-13 2008-09-16 Vaccine compositions comprising a saponin adjuvant
HK08110254.2A HK1118477A1 (en) 2005-12-13 2008-09-16 Immunogenic composition comprising an adjuvant
US13/020,045 US10039823B2 (en) 2005-12-13 2011-02-03 Vaccine compositions comprising a saponin adjuvant
HR20120136T HRP20120136T1 (en) 2005-12-13 2012-02-10 Immunogenic composition comprising an adjuvant
CY20121100324T CY1112589T1 (en) 2005-12-13 2012-03-30 IMMUNOLOGICAL COMPOSITION CONTAINING IMMUNOLOGY
JP2012256348A JP2013056927A (en) 2005-12-13 2012-11-22 Vaccine composition comprising saponin adjuvant
HRP20131057TT HRP20131057T1 (en) 2005-12-13 2013-11-06 Vaccine compositions comprising a saponin adjuvant
IL229521A IL229521A0 (en) 2005-12-13 2013-11-20 Novel composition
CY20131101050T CY1114864T1 (en) 2005-12-13 2013-11-22 VACCINE COMPOSITIONS CONTAINING A SAPONINI EXTRACTIVE EXCIPIENT
HRP20140484TT HRP20140484T1 (en) 2005-12-13 2014-05-28 Vaccine compositions comprising a saponin adjuvant
CY20141100461T CY1115308T1 (en) 2005-12-13 2014-06-25 VACCINE COMPOSITIONS CONTAINING AN IMMUNE SAPONIN EXCIPIENT
US15/354,233 US10143745B2 (en) 2005-12-13 2016-11-17 Vaccine compositions comprising a saponin adjuvant
ARP170101607A AR108718A2 (en) 2005-12-13 2017-06-13 COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0525321.6A GB0525321D0 (en) 2005-12-13 2005-12-13 Novel compositions

Publications (1)

Publication Number Publication Date
GB0525321D0 true GB0525321D0 (en) 2006-01-18

Family

ID=35736013

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0525321.6A Ceased GB0525321D0 (en) 2005-12-13 2005-12-13 Novel compositions

Country Status (5)

Country Link
CN (1) CN101330924A (en)
AR (1) AR108718A2 (en)
GB (1) GB0525321D0 (en)
UA (1) UA98612C2 (en)
ZA (1) ZA200805025B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101690810B (en) * 2009-10-21 2011-08-17 辽宁益康生物股份有限公司 Tetravalent inactivated vaccine adjuvant against Newcastle Disease, infectious bronchitis, egg drop syndrome and bird flu and preparation method thereof
US20140072622A1 (en) * 2011-05-17 2014-03-13 Glaxosmithkline Biologicals S.A. Vaccine against streptococcus pneumoniae
GB201213364D0 (en) * 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
JP6290918B2 (en) * 2012-12-05 2018-03-07 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Immunogenic composition
CN105530953A (en) * 2013-10-03 2016-04-27 日东电工株式会社 Injectable vaccine composition
CN108853493A (en) * 2018-07-26 2018-11-23 中国人民解放军陆军军医大学 Ophiopogonin D and its nano-emulsion are preparing the application in vaccine adjuvant

Also Published As

Publication number Publication date
CN101330924A (en) 2008-12-24
ZA200805025B (en) 2009-10-28
UA98612C2 (en) 2012-06-11
AR108718A2 (en) 2018-09-19

Similar Documents

Publication Publication Date Title
IL229521A0 (en) Novel composition
IL191572A0 (en) Pestcidal compositions
GB0503337D0 (en) Compositions
IL186721A0 (en) Bioenhanced compositions
IL185901A0 (en) Novel composition
EP1930012A4 (en) Cellooligosaccharide-containing composition
GB0526283D0 (en) Compositions
IL186093A0 (en) Lignan-containing compositions
GB0501365D0 (en) Compositions
GB0501192D0 (en) Stable prostaglandin-containing compositions
EP1865042A4 (en) Frost-preventive composition
GB0524128D0 (en) Compositions
GB0502479D0 (en) Novel compositions
IL190321A0 (en) Compositions containing saratin
EP1847249A4 (en) Hairdye composition
GB0502475D0 (en) Novel compositions
ZA200709913B (en) Bioenhanced compositions
EP1947129A4 (en) Photoradial- and photocation-curable composition
EP1864573A4 (en) Agricultural-chemical composition
GB0525321D0 (en) Novel compositions
GB0505760D0 (en) Novel composition
GB0526282D0 (en) Compositions
GB0502341D0 (en) Composition
GB0524803D0 (en) Novel compositions
GB0513367D0 (en) Novel composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)